VDAC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.684800E-01
Normal-vs-Stage2
8.191800E-01
Normal-vs-Stage3
5.084600E-01
Normal-vs-Stage4
6.017800E-01
Stage1-vs-Stage2
7.104000E-01
Stage1-vs-Stage3
4.166800E-01
Stage1-vs-Stage4
5.614800E-01
Stage2-vs-Stage3
3.945200E-01
Stage2-vs-Stage4
6.826800E-01
Stage3-vs-Stage4
7.942800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.176400E-01
Normal-vs-AfricanAmerican
5.897200E-01
Normal-vs-Asian
8.073600E-01
Caucasian-vs-AfricanAmerican
6.925200E-01
Caucasian-vs-Asian
4.040000E-01
AfricanAmerican-vs-Asian
3.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.759400E-01
Normal-vs-Female
9.287600E-01
Male-vs-Female
3.545400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.419800E-01
Normal-vs-Age(41-60Yrs)
8.683600E-01
Normal-vs-Age(61-80Yrs)
7.199200E-01
Normal-vs-Age(81-100Yrs)
9.734000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.229800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.423000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.995800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.677700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.134000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.718600E-01
Normal-vs-Daily Drinker
6.757200E-01
Normal-vs-Weekly Drinker
9.821600E-01
Normal-vs-Occasional Drinker
9.420800E-01
Normal-vs-Social Drinker
8.110200E-01
Non Drinker-vs-Daily Drinker
6.380600E-01
Non Drinker-vs-Weekly Drinker
2.067000E-01
Non Drinker-vs-Occasional Drinker
1.280600E-01
Non Drinker-vs-Social Drinker
7.757800E-02
Daily Drinker-vs-Weekly Drinker
4.671600E-01
Daily Drinker-vs-Occasional Drinker
3.500000E-01
Daily Drinker-vs-Social Drinker
2.461600E-01
Weekly Drinker-vs-Occasional Drinker
8.722200E-01
Weekly Drinker-vs-Social Drinker
6.804800E-01
Occasional Drinker-vs-Social Drinker
8.006600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.956200E-01
Normal-vs-Grade 2
6.821400E-01
Normal-vs-Grade 3
6.287600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.654600E-01
Grade 1-vs-Grade 3
1.212030E-01
Grade 1-vs-Grade 4
4.956200E-01
Grade 2-vs-Grade 3
1.979640E-01
Grade 2-vs-Grade 4
6.821400E-01
Grade 3-vs-Grade 4
6.287600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.459800E-01
Normal-vs-NonDiabetic
8.366200E-01
Diabetic-vs-NonDiabetic
5.466000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.702200E-01
Normal-vs-NoPancreatitis
7.796800E-01
Pancreatitis-vs-NoPancreatitis
2.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.993000E-01
Normal-vs-N1
8.456200E-01
N0-vs-N1
7.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.192000E-01
Normal-vs-TP53-NonMutant
2.373400E-01
TP53-Mutant-vs-TP53-NonMutant
4.134000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
